InvestorsHub Logo
Followers 51
Posts 4564
Boards Moderated 0
Alias Born 12/14/2009

Re: longfellow95 post# 233537

Monday, 06/17/2019 2:59:41 AM

Monday, June 17, 2019 2:59:41 AM

Post# of 690899
I know it is Keytruda. It was a typing error. Assessing people on typing errors is a sign of weakness.
Page 9 https://d1io3yog0oux5.cloudfront.net/_b785840b5bd19c408c9e8db633fb660b/oncolyticsbiotech/db/300/2426/pdf/6.13.19+-+Corporate+Presentation.pdf

https://ir.oncosec.com/press-releases/detail/1998/ucsf-doses-first-patient-in-triple-combination-clinical


https://www.rexahn.com/product-pipeline For example RX-5902

https://www.leaptx.com

Already 4 examples of non-chemotherapeutic treatments using Keytruda in combination.
Looking to recent buyout Numbers in oncology >$20b is not too far fetched.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News